Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway.

RNA levels are widely thought to be predictive of RNA function. However, the existence of more than a hundred chemically distinct modifications of RNA alone is a major indication that these moieties may impart distinct functions to subgroups of RNA molecules that share a primary sequence but display...

Full description

Bibliographic Details
Main Authors: Samantha B Shelton, Calder Reinsborough, Blerta Xhemalce
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-07-01
Series:PLoS Genetics
Online Access:http://europepmc.org/articles/PMC4956115?pdf=render
id doaj-a0337f9db4164fc294a8cbab0627b676
record_format Article
spelling doaj-a0337f9db4164fc294a8cbab0627b6762020-11-25T02:49:24ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042016-07-01127e100613910.1371/journal.pgen.1006139Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway.Samantha B SheltonCalder ReinsboroughBlerta XhemalceRNA levels are widely thought to be predictive of RNA function. However, the existence of more than a hundred chemically distinct modifications of RNA alone is a major indication that these moieties may impart distinct functions to subgroups of RNA molecules that share a primary sequence but display distinct RNA "epigenetic" marks. RNAs can be modified on many sites, including 5' and 3' ends, the sugar phosphate backbone, or internal bases, which collectively provide many opportunities for posttranscriptional regulation through a variety of mechanisms. Here, we will focus on how modifications on messenger and microRNAs may affect the process of RNA interference in mammalian cells. We believe that taking RNA modifications into account will not only advance our understanding of this crucial pathway in disease and cancer but will also open the path to exploiting the enzymes that "write" and "erase" them as targets for therapeutic drug development.http://europepmc.org/articles/PMC4956115?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Samantha B Shelton
Calder Reinsborough
Blerta Xhemalce
spellingShingle Samantha B Shelton
Calder Reinsborough
Blerta Xhemalce
Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway.
PLoS Genetics
author_facet Samantha B Shelton
Calder Reinsborough
Blerta Xhemalce
author_sort Samantha B Shelton
title Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway.
title_short Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway.
title_full Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway.
title_fullStr Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway.
title_full_unstemmed Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway.
title_sort who watches the watchmen: roles of rna modifications in the rna interference pathway.
publisher Public Library of Science (PLoS)
series PLoS Genetics
issn 1553-7390
1553-7404
publishDate 2016-07-01
description RNA levels are widely thought to be predictive of RNA function. However, the existence of more than a hundred chemically distinct modifications of RNA alone is a major indication that these moieties may impart distinct functions to subgroups of RNA molecules that share a primary sequence but display distinct RNA "epigenetic" marks. RNAs can be modified on many sites, including 5' and 3' ends, the sugar phosphate backbone, or internal bases, which collectively provide many opportunities for posttranscriptional regulation through a variety of mechanisms. Here, we will focus on how modifications on messenger and microRNAs may affect the process of RNA interference in mammalian cells. We believe that taking RNA modifications into account will not only advance our understanding of this crucial pathway in disease and cancer but will also open the path to exploiting the enzymes that "write" and "erase" them as targets for therapeutic drug development.
url http://europepmc.org/articles/PMC4956115?pdf=render
work_keys_str_mv AT samanthabshelton whowatchesthewatchmenrolesofrnamodificationsinthernainterferencepathway
AT calderreinsborough whowatchesthewatchmenrolesofrnamodificationsinthernainterferencepathway
AT blertaxhemalce whowatchesthewatchmenrolesofrnamodificationsinthernainterferencepathway
_version_ 1724743796561805312